GeoVax Labs, Inc. (GOVX) Revenue History
Annual and quarterly revenue from 1996 to present
GOVX Revenue Over Time (1996–2025)
GOVX Revenue Growth History
10 of 24 years with positive growth- FY1996 revenue growth
- N/A
- FY1997 revenue growth
- +2805.9%
- FY1998 revenue growth
- +96.6%
- FY1999 revenue growth
- -57.5%
- FY2000 revenue growth
- -62.3%
- FY2001 revenue growth
- +204.7%
- FY2003 revenue growth
- -100.0%
- FY2004 revenue growth
- N/A
- FY2005 revenue growth
- N/A
- FY2006 revenue growth
- N/A
- FY2007 revenue growth
- -72.2%
- FY2008 revenue growth
- +1127.9%
- FY2009 revenue growth
- +26.0%
- FY2010 revenue growth
- +41.4%
- FY2011 revenue growth
- -5.5%
- FY2012 revenue growth
- -45.8%
- FY2013 revenue growth
- -9.0%
- FY2014 revenue growth
- -63.5%
- FY2015 revenue growth
- -51.5%
- FY2016 revenue growth
- +93.6%
- FY2017 revenue growth
- +29.7%
- FY2018 revenue growth
- -10.4%
- FY2019 revenue growth
- +22.1%
- FY2020 revenue growth
- +55.1%
- FY2021 revenue growth
- -78.9%
- FY2022 revenue growth
- -78.9%
- FY2023 revenue growth
- -100.0%
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- -37.1%
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $0 | -100.0% |
| Q1 2026 | $0 | -100.0% |
| Q4 2025 | $0 | -100.0% |
| Q3 2025 | $0 | -100.0% |
| Q2 2025 | $852K | +183.5% |
| Q1 2025 | $1.6M | — |
| Q4 2024 | $864K | — |
| Q3 2024 | $2.8M | — |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2022)
GOVX's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
GOVX Revenue Analysis (1996–2025)
Current Revenue & Growth
As of November 8, 2026, GeoVax Labs, Inc. (GOVX) generated trailing twelve-month (TTM) revenue of $0, reflecting significant decline in growth of -100.0% year-over-year. The most recent quarter (Q2 2026) recorded $0 in revenue
Historical Growth Trajectory
GOVX's 5-year compound annual growth rate (CAGR) stands at +6.4%, indicating steady revenue expansion. The 3-year CAGR of +212.5% exceeds the 5-year average, indicating an acceleration in the most recent period. GeoVax Labs, Inc.'s highest annual revenue of $5.4 million was recorded in 1998.
Revenue by Segment
GOVX's revenue is primarily driven by NIH Grants (100%). With over half of revenue concentrated in NIH Grants, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including NVAX (-61.3% YoY), IOVA (+51.3% YoY), and SIGA (-70.1% YoY) — GOVX has underperformed the peer group in revenue growth. Compare GOVX vs NVAX →
GOVX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| GOVXCurrent | $0 | -100.0% | +6.4% | -869.3% | |
 NVAX | $1.1B | -61.3% | +118.8% | 50.1% | |
 IOVA | $264M | +51.3% | - | -151.1% | |
 SIGA | $95M | -70.1% | -5.4% | 25.1% | |
 AGEN | $114M | +25.4% | +5.3% | -18.0% |
GOVX Historical Revenue Data (1996–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $2.5M | -37.1% | $-15,632,374 | -628.0% | $-21,639,047 | -869.3% |
| 2024 | $4.0M | - | $3.9M | 97.6% | $-25,144,280 | -635.8% |
| 2023 | $0 | -100.0% | $-20,720,766 | - | $-26,742,939 | - |
| 2022 | $82K | -78.9% | $-9,041,953 | -11090.9% | $-14,028,564 | -17207.5% |
| 2021 | $386K | -78.9% | $-15,168,670 | -3934.8% | $-18,745,823 | -4862.7% |
| 2020 | $1.8M | +55.1% | $1.8M | 100.0% | $-2,816,815 | -154.5% |
| 2019 | $1.2M | +22.1% | $1.2M | 100.0% | $-2,372,493 | -201.8% |
| 2018 | $963K | -10.4% | $-915,652 | -95.1% | $-2,563,000 | -266.1% |
| 2017 | $1.1M | +29.7% | $-942,080 | -87.6% | $-2,174,448 | -202.2% |
| 2016 | $829K | +93.6% | $-1,141,941 | -137.8% | $-3,273,367 | -394.9% |
| 2015 | $428K | -51.5% | $-1,265,021 | -295.5% | $-2,694,752 | -629.5% |
| 2014 | $883K | -63.5% | $-930,013 | -105.3% | $-2,737,618 | -310.1% |
| 2013 | $2.4M | -9.0% | $-497,328 | -20.6% | $-2,289,488 | -94.7% |
| 2012 | $2.7M | -45.8% | $-386,522 | -14.5% | $-2,139,000 | -80.5% |
| 2011 | $4.9M | -5.5% | $4.9M | 100.0% | $-2,349,045 | -47.9% |
GOVX Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
30+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GOVX — Frequently Asked Questions
Quick answers to the most common questions about buying GOVX stock.
Is GOVX's revenue growth accelerating or slowing?
GOVX revenue is declining -100.0% year-over-year. TTM revenue fell to $0.00, contrasting with the 5-year CAGR of +6.4%. The reversal reflects either macro headwinds or company-specific challenges.
What is GOVX's revenue history from 1996 to 2026?
GeoVax Labs, Inc. (GOVX) revenue history spans 1996 to 2026. TTM revenue as of 2026 is $0.00, growing at -100.0% YoY. The 5-year CAGR is +6.4%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is GOVX's long-term revenue growth rate (CAGR)?
GeoVax Labs, Inc.'s 5-year revenue CAGR of +6.4% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -100.0% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for GOVX.
Why does GOVX's quarterly revenue fluctuate?
GOVX quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. GeoVax Labs, Inc.'s revenue data from 1996 to 2026 shows full historical quarterly detail on this page.
How is GOVX's revenue distributed by segment?
GOVX reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does GOVX's revenue compare to industry peers?
GeoVax Labs, Inc. (GOVX) with TTM revenue of $0.00 and -100.0% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.